https://www.selleckchem.com/pr....oducts/Everolimus(RA
The late survival was 43.8% ± 5.89% at 10 years and was comparable among eras (P = 0.44). The cumulative incidence of reoperation at 10 years was 14.1% (2.3-26. in biological valves and 4.9% (0.1-10.3) in mechanical valves (P = 0.25). CONCLUSIONS Patient characteristics, potential risk factors and patient outcome changed considerably over time in patients undergoing TVR. Notably, there was a shift in aetiology, completely altering the patient population and their characteristics. © The Author(s) 2020. Published by Oxford Un
Like
Comment
Share
